Skip to main content
Premium Trial:

Request an Annual Quote

Pangea Systems Unveils Bioinformatics Dataset


OAKLAND, Calif.--Privately held computer developer Pangea Systems announced the release of the first commercially available bioinformatics metabolic pathways dataset for E. coli last week. EcoCyc 4.0 allows researchers to access an integrated metabolic pathways dataset and software environment that links the complete metabolic network and the entire genome of a biomedically important model organism. A graphical user interface enables biologically intuitive exploration of cellular metabolism, the company said. This can be done by visualizing individual pathways or the entire metabolic map.

Pangea said EcoCyc represents its latest commitment to accelerating and simplifying the drug discovery process by providing integrated database management, analysis algorithms, and visualization tools for biological and chemical information.

EcoCyc 4.0 is available through the Web and links approximately 2,000 more genes than the previously available version. Additionally, EcoCyc 4.0 goes beyond earlier E. coli metabolic pathway descriptions by adding two-component signal transduction proteins, the company said. EcoCyc is available at

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.